Clinical Trial Update: Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating induction chemotherapy followed by cetuximab-based chemoradiation in head and neck cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Institute of Oncology Ljubljana | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED